Cartalax is a peptide-based bioregulator composed of short-chain amino acids (specifically L-Alanine, L-Glutamic Acid, and L-Aspartic Acid), developed to support the function of cartilage tissue and the musculoskeletal system. It works by regulating metabolic processes in chondrocytes-the cells responsible for maintaining healthy cartilage-thereby promoting tissue repair, reducing degenerative changes, and improving joint mobility.
